News Novo Nordisk Pharma

Important Milestone for Novo Nordisk: FDA Approves Oral Version of its Type 2 Diabetes Drug Semaglutide (Rybelsus)

Biotech News | 21.09.2019

This are great news for the Danish diabetes specialist Novo Nordisk. The American healthcare...